Literature DB >> 1976120

A congenic line of the DDD mouse strain, DDD/1-Mtv-2/Mtv-2: establishment and mammary tumorigenesis.

A Matsuzawa1, K Sayama, A Tsubura, A Murakami.   

Abstract

A single dominant gene on chromosome 18, Mtv-2, controls both the early appearance of mammary tumors and expression of mouse mammary tumor virus (MMTV) in the milk. A congenic DDD mouse strain, DDD/1-Mtv-2/Mtv-2 (DDD-Mtv-2), was developed by introducing this gene from GRS/AJms (GR) into DDD/1 mice by repeating 12 backcrosses and subsequent inbreeding using mammary tumors as a marker for selection. Southern blot analysis of the liver DNA from the resulting congenic mice with EcoRI and MMTV-U3 prove revealed that two DNA fragments corresponding to Mtv-2 were specifically transferred from GR to congenic mice. Detection of MMTV-gp52 antigen in the mammary gland and mammary tumor development in DDDfDDD-Mtv-2 mice demonstrated the production of infectious mature MMTV by Mtv-2 in congenic mice. About 80% of breeding DDD-Mtv-2 females developed mammary tumors in the course of one-year follow-up. The tumor incidence was lower and the tumor age higher than those in GR mice, suggesting less active functioning of the gene on the DDD genetic background. About 70% of these tumors were morphologically classified as pale cell and type P carcinomas peculiar to GR mice. The gene seemed to control the histologic features of mammary tumors. Congenic mice carried an MMTV provirus in an incomplete form on Y chromosome. The DDD-Mtv-2-strain will provide a new model for biological and molecular researches into mouse mammary tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976120      PMCID: PMC6504069          DOI: 10.1111/j.1349-7006.1990.tb02621.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  1 in total

1.  Characterization of mammary plaques in DDD mice congenic for Mtv-2 gene, DDD/1-Mtv-2/Mtv-2.

Authors:  A Matsuzawa; T Kaneko; Y Takeda; A Murakami; A Tsubura
Journal:  Jpn J Cancer Res       Date:  1993-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.